Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Psilocybin × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Other neoplasm 1

Conditions

Interventions

Whole-Body Irradiation 4 Sulindac 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 fludarabine phosphate 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Cetuximab 3 Tacrolimus 2 Sirolimus 2 Selenium 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Oxycodone 2 Mycophenolic Acid 2 Melphalan 2 Gene Expression Profiling 2 Etoposide 2 Darbepoetin alfa 2 Cyclosporine 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 Biopsy 2 Aspirin 2 Aminolevulinic Acid 2 Albumin-Bound Paclitaxel 2 vandetanib 1 soybean oil, phospholipid emulsion 1 polyphenon E 1 perillyl alcohol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04950608 2026-02-17

PATH

Dana-Farber Cancer Institute

Phase 2 Completed

15 enrolled 26 charts

Hospice

Data powered by HemOnc (CC BY 4.0) Colophon ⚡